Geographical segregation and IL-6: A marker of chronic inflammation in older adults

Biomarkers in Medicine

Volumn 2, Issue 4, 2008, Pages 335-348

  Purser, Jama L ^a,b   Kuchibhatla, Maragatha N ^a,b   Miranda, Marie L ^c   Blazer, Dan G ^a,b   Cohen, Harvey J ^a,b   Fillenbaum, Gerda G ^a,b,d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Elderly; Environmental impact; Health risk; IL 6; Inflammatory marker; Longitudinal study

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6;

AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC INFLAMMATION; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DEPENDENT VARIABLE; DISEASE MARKER; ENVIRONMENTAL FACTOR; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MINORITY GROUP; POPULATION RESEARCH; POVERTY; PROSPECTIVE STUDY; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS;

EID: 54849437933     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/17520363.2.4.335     Document Type: Article

References (44)

1. US EPA (Environmental Protection Agency): Aging and Toxic Response: Issues Relative to Risk Assessment. National Center for Environmental Assessment, Washington, DC, USA. Available from the National Technical Information Service, Springfield, VA (202), 564-3261 (2006).
2. Geller AM, Zenick H: Aging and the environment: a research framework. Env. Health Perspect. 113(9), 1257-1262 (2005).
3. Hood E: Toward a new understanding of aging. Env. Health Perspect. 111(14), A756-A758 (2003).
4. Albertini R, Bird M, Doerer N et al.: The use of biomonitoring data in exposure and human health risk assessments. Env. Health Perspect. 114(11), 1755-1762 (2006).
5. Morbidity and Mortality Weekly Report: Surveillance Summaries: USA 1997-2001. 52(SS10), 1 (2003).
6. Miranda ML, Dolinoy D, Overstreet MA: Mapping for prevention: GIS models for directing childhood lead poisoning prevention programs. Env. Health Perspect. 110(9), 947-953 (2002).
7. Cornoni-Huntley J, Blazer D, Lafferty M et al.: Established Populations for Epidemiologic Studies of the Elderly: Resource Data Book (Volume 2). PHS, NIH Publication No.: 90-495, Washington, DC, USA (1990).
8. Blazer DG, Burchett B, Service C, George LK: The association of age and depression among the elderly: an epidemiologic exploration. J. Gerontol. Med. Sci. 46(6), M210-M215 (1991).
9. Cohen HJ, Harris T, Pieper CF: Coagulation and activation of inflammatory pathways in the development of functional decline and mortality. Am. J. Med. 114(3), 180-187 (2003).
10. Cohen HJ, Pieper CF, Harris T, Rao KMK, Currie MS: The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J. Gerontol. Med. Sci. 52A(4), M201-M208 (1997).
11. Dentino AN, Pieper CF, Rao MK et al.: Association of interleukin-6 and other biologic variables with depression in older people living in the community. J. Am. Geriatr. Soc. 47(1), 6-11 (1999).
12. Wilson CJ, Cohen HJ, Pieper CF: Cross-linked fibrin degradation products (D-dimer), plasma cytokines, and cognitive decline in community-dwelling elderly persons. J. Am. Geriatr. Soc. 51(10), 1374-1381 (2003).
13. Visser M, Pahor M, Taaffe D et al.: Relationship of IL-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: the Health ABC study. J. Gerontol. Med. Sci. 57A(5), M326-M332 (2002).
14. Roubenoff R, Parise H, Payette HA et al.: Cytokines, insulin-like growth factor-1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am. J. Med. 115(6), 429-435 (2003).
15. Roubenoff R: Catabolism of aging: is it an inflammatory process? Curr. Opin. Clin. Nutr. Metab. Care 6(3), 295-299 (2003).
16. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann. Int. Med. 128(2), 127-137 (1998).
17. Wilson CJ, Finch CE, Cohen HJ: Cytokines and cognition: the case for a head-to-toe inflammatory paradigm. J. Am. Geriatr. Soc. 50(12), 2041-2056 (2002).
18. Bruunsgaard H, Pedersen B: Age-related inflammatory cytokines and disease. Immunol. Allergy Clin. North Am. 23(1), 15-39 (2003).
19. Franceschi C, Bonafe M, Valensin S et al.: Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. NY Acad. Sci. 908, 244-254 (2000).
20. Franceschi C, Valensin S, Fagnoni F, Barbi C, Bonafe M: Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load. Exp. Gerontol. 34(8), 911-921 (1999).
21. Franceschi C, Bonafe M: Centenarians as a model for healthy aging. Biochem. Soc. Trans. 31, 457-461 (2003).
22. Boren E, Gershwin ME: Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmune Rev. 3(5), 401-406 (2004).
23. Ness RB, Catherine L, Haggerty CL, Harger G, Ferrell R: Differential distribution of allelic variants in cytokine genes among African-Americans and White Americans. Am. J. Epidemiol. 160(11), 1033-1038 (2004).
24. Zabaleta J, Schneider BG, Ryckman K et al.: Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development. Cancer Immunol. Immunother. 57, 107-114 (2008).
25. Hassan MI, Aschner Y, Manning CH, Xu J, Aschner JL: Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North Carolina. Cytokine 21, 10-16 (2003).
26. Institute of Medicine: Toward Environmental Justice: Research, Education, and Health Policy Needs. National Academy Press, Washington, DC, USA (1999).
27. Satcher D: Ethnic disparities in health: the public's role in working for equality. PLoS Med. 10, 1683-1685 (2006).
28. Payne-Sturgess D, Gee GC, Crowder K et al.: Workshop summary: connecting social and environmental factors to measure and track environmental health disparities. Environ. Res. 102, 146-153 (2006).
29. Rao KM, Pieper CS, Currie MS, Cohen HJ: Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am. J. Clin. Pathol. 102(6), 802-805 (1994).
30. United States Bureau of the Census, US Department of Commerce, Economics, and Statistics, Washington, DC, USA (1991).
31. Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R: Choosing area-based socioeconomic measures to monitor social inequalities in low birth weight and childhood lead poisoning: The Public Health Disparities Geocoding Project (USA). J. Epidemiol. Community Health. 57(3), 186-199 (2003).
32. Krabbe KS, Pedersen M, Bruunsgard H: Inflammatory mediators in the elderly. Exp. Gerontol. 39(5), 687-699 (2004).
33. US Census Bureau. Statistical Abstract of the United States (Table 702). Purchasing power of the dollar: 1950-2006. Washington, DC, USA, 467 (2008).
34. WHO Consultation on Obesity: WHO Technical Report Series 894. World Health Organization, Geneva, Switzerland (2000).
35. Blazer DG, Fillenbaum GG, Gold DT, Burchett BM, Hays JC: APOE E4 as a predictor of subjective quality of life in a biracial older person community sample. J. Aging Health 15(4), 645-660 (2003).
36. Katz S, Akpom CA: A measure of primary sociobiological functions. Int. J. Health Services 6(3), 493-507 (1976).
37. Fillenbaum GG: Screening the elderly: a brief instrumental ADL measure. J. Am. Geriatr. Soc. 33(10), 698-706 (1985).
38. Rosow I, Breslau N: A Guttman health scale for the aged. J. Gerontol. 21(4), 556-559 (1966).
39. Radloff L: The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychological Measurement 1, 385-401 (1977).
40. Pfeiffer E: A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J. Am. Geriatr. Soc. 23, 433-441 (1975).
41. Dixon WJ (Ed.). BMDP Statistical Software. University of California Press, Berkeley, CA, USA (1983).
42. Jenks GF, Caspall FC: Error on choroplethic maps: definition, measurement, reduction. Ann. Assoc. Am. Geogr. 61, 217-244 (1971).
43. Office of Minority Health and Health Disparities and State Center for Health Statistics, North Carolina Department of Health and Human Services. Racial and Ethnic Health Disparities in North Carolina Report Card (2006).
44. Danesh J, Kaptoge S, Mann AG et al.: Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 5(4), 600-610 (2008).